Accordingly, we performed a lipid metabolite profiling analysis on NPC cells with over-expression of DHRS2 and the control, to identify critical FA metabolite alteration that may contribute to the role of DHRS2 in NPC progression. The gene discussed is DHRS2; the disease is nasopharyngeal carcinoma.